ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

INAB IN8bio Inc

1.23
0.02 (1.65%)
Last Updated: 10:00:42
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
IN8bio Inc INAB NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.02 1.65% 1.23 10:00:42
Open Price Low Price High Price Close Price Prev Close
1.20 1.20 1.23 1.21
more quote information »

Recent News

Date Time Source Heading
3/27/202410:52IHNWFeaturedPOET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks
3/14/202416:00GLOBEIN8bio Reports Fourth Quarter and Full-Year 2023 Financial..
3/05/202416:30GLOBEIN8bio to Present New Preclinical Data on Novel Gamma-Delta..
2/26/202408:00BWIN8bio to Present at Upcoming Investor Conferences
2/14/202408:00GLOBEIN8bio Announces Publication on Novel Gamma-Delta T Cell..
2/08/202416:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/08/202416:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/08/202416:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/08/202416:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/08/202416:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/08/202416:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/19/202416:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
1/19/202400:15EDGAR2Form EFFECT - Notice of Effectiveness
1/18/202416:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
1/12/202417:16EDGAR2Form S-3 - Registration statement under Securities Act of..
1/04/202408:00GLOBEIN8bio Highlights Recent Company Accomplishments and..
12/15/202316:31EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/15/202308:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/15/202308:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/15/202308:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/15/202308:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/15/202308:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/15/202308:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/15/202308:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/15/202306:02EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/14/202306:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/11/202317:15EDGAR2Form 8-K - Current report
12/11/202316:05GLOBEIN8bio Announces Positive Clinical Update Demonstrating..
12/11/202309:00GLOBEIN8bio Announces Pricing of Financing Totaling up to $46.9..
12/11/202308:56EDGAR2Form 8-K - Current report
12/08/202316:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/08/202316:24EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/07/202316:15EDGAR2Form 8-K - Current report
12/07/202308:00GLOBEIN8bio Appoints Dr. Corinne Epperly to Board of Directors
12/05/202308:00GLOBEIN8bio to Host Investor Call at 8:30 AM ET on Tuesday,..
11/20/202309:04EDGAR2Form 8-K - Current report
11/20/202307:00GLOBEIN8bio’s INB-200 Demonstrates Extended Progression-Free..
11/10/202307:00GLOBEIN8bio to Present Data Highlighting Potential of INB-200 and..
11/09/202316:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/202316:03EDGAR2Form 8-K - Current report
11/09/202316:00GLOBEIN8bio Reports Third Quarter 2023 Financial Results and..
11/06/202308:00GLOBEIN8bio Presents Biologic Correlative Data from the INB-200..
11/03/202312:00GLOBEIN8bio Presents Positive Data Update from Induced..
11/02/202309:17GLOBEIN8bio to Present New Positive Data from Phase 1 Trial of..
11/01/202308:00GLOBEIN8bio to Participate at the 2023 Truist Securities..
10/12/202308:09EDGAR2Form 8-K - Current report
10/12/202308:00GLOBEIN8bio Completes Dose Escalation in Phase 1 Trial of..
9/29/202308:00GLOBEIN8bio Announces Presentations at the Society for Immunology..
9/26/202308:00GLOBEIN8bio to Host Research & Development Day on its Gamma-Delta..
9/20/202308:00GLOBEIN8bio to Participate at the 2023 Cantor Fitzgerald Global..
9/19/202308:03GLOBEIN8bio Strengthens Intellectual Property Portfolio with..

Your Recent History

Delayed Upgrade Clock